首页 > 最新文献

Revista Espanola De Enfermedades Digestivas最新文献

英文 中文
Relative fat mass and constipation in United States adults ‒ A cross-sectional study of 11,380 participants from NHANES 2005-2010. 美国成年人的相对脂肪量和便秘:一项来自NHANES 2005-2010的11,380名参与者的横断面研究。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2025.11391/2025
Min Lv, Xiaxi Wu, Wei Wang

Background: constipation is a common gastrointestinal disorder closely associated with obesity. Relative fat mass (RFM) is a newer anthropometric index that offers a more precise reflection of body fat distribution than traditional methods. Despite its advantages, the potential link between RFM and the likelihood of experiencing constipation has not been thoroughly examined. This study was therefore designed to explore the association between RFM and constipation Methods: data were obtained from the 2005-2010 cycles of the National Health and Nutrition Examination Survey (NHANES). Constipation was defined using the Bristol Stool Form Scale and questionnaire responses. Weighted multivariable logistic regression models were employed to evaluate the association between RFM and constipation. Propensity score matching (PSM) was used to balance baseline covariates between groups. Analyses were conducted both before and after PSM to test the robustness of the findings. Smooth curve fitting and threshold effect analyses were conducted to explore potential nonlinear relationships. Subgroup analyses and interaction tests were used to assess possible heterogeneity across different population strata.

Results: a total of 11,380 participants were included in the final analysis, among whom 1,206 were classified as having constipation. Logistic regression revealed that in the fully adjusted model, each one-unit increase in RFM was associated with a 2.9 % reduction in the odds of constipation (OR = 0.971, 95 % CI: 0.956-0.986, p = 0.0011). Furthermore, PSM analyses confirmed the robustness of the results. The inverse association between RFM and constipation was more pronounced among individuals aged > 45 years, those with hypertension, and those who did not consume alcohol (all p for interaction < 0.05). Smooth curve fitting and threshold effect analysis indicated a nonlinear relationship, with an inflection point at an RFM of 36.06.

Conclusion: our study suggests a significant inverse association between RFM and constipation. Further prospective studies are warranted to validate this relationship.

便秘是一种常见的与肥胖密切相关的胃肠道疾病。相对脂肪量(RFM)是一种较新的人体测量指标,它比传统方法更准确地反映了身体脂肪的分布。尽管RFM具有优势,但其与便秘可能性之间的潜在联系尚未得到彻底研究。因此,本研究旨在探讨RFM与便秘之间的关系方法数据来自2005-2010周期的国家健康与营养检查调查(NHANES)。便秘的定义采用布里斯托大便量表和问卷调查。采用加权多变量logistic回归模型评估RFM与便秘之间的关系。使用倾向评分匹配(PSM)来平衡组间的基线协变量。在PSM之前和之后都进行了分析,以测试结果的稳健性。通过光滑曲线拟合和阈值效应分析来探索潜在的非线性关系。亚组分析和相互作用检验用于评估不同人群阶层间可能存在的异质性。结果共有11,380名参与者被纳入最终分析,其中1,206人被归类为便秘。Logistic回归显示,在完全调整模型中,RFM每增加1个单位,便秘发生率降低2.9% (OR = 0.971, 95%CI: 0.956-0.986, p = 0.0011)。此外,PSM分析证实了结果的稳健性。RFM与便秘之间的负相关关系在年龄在0 ~ 45岁之间、高血压患者和不饮酒的人群中更为明显(相互作用p均< 0.05)。平滑曲线拟合和阈值效应分析均显示出非线性关系,在RFM为36.06处出现拐点。结论本研究提示RFM与便秘呈显著负相关。需要进一步的前瞻性研究来验证这种关系。
{"title":"Relative fat mass and constipation in United States adults ‒ A cross-sectional study of 11,380 participants from NHANES 2005-2010.","authors":"Min Lv, Xiaxi Wu, Wei Wang","doi":"10.17235/reed.2025.11391/2025","DOIUrl":"10.17235/reed.2025.11391/2025","url":null,"abstract":"<p><strong>Background: </strong>constipation is a common gastrointestinal disorder closely associated with obesity. Relative fat mass (RFM) is a newer anthropometric index that offers a more precise reflection of body fat distribution than traditional methods. Despite its advantages, the potential link between RFM and the likelihood of experiencing constipation has not been thoroughly examined. This study was therefore designed to explore the association between RFM and constipation Methods: data were obtained from the 2005-2010 cycles of the National Health and Nutrition Examination Survey (NHANES). Constipation was defined using the Bristol Stool Form Scale and questionnaire responses. Weighted multivariable logistic regression models were employed to evaluate the association between RFM and constipation. Propensity score matching (PSM) was used to balance baseline covariates between groups. Analyses were conducted both before and after PSM to test the robustness of the findings. Smooth curve fitting and threshold effect analyses were conducted to explore potential nonlinear relationships. Subgroup analyses and interaction tests were used to assess possible heterogeneity across different population strata.</p><p><strong>Results: </strong>a total of 11,380 participants were included in the final analysis, among whom 1,206 were classified as having constipation. Logistic regression revealed that in the fully adjusted model, each one-unit increase in RFM was associated with a 2.9 % reduction in the odds of constipation (OR = 0.971, 95 % CI: 0.956-0.986, p = 0.0011). Furthermore, PSM analyses confirmed the robustness of the results. The inverse association between RFM and constipation was more pronounced among individuals aged > 45 years, those with hypertension, and those who did not consume alcohol (all p for interaction < 0.05). Smooth curve fitting and threshold effect analysis indicated a nonlinear relationship, with an inflection point at an RFM of 36.06.</p><p><strong>Conclusion: </strong>our study suggests a significant inverse association between RFM and constipation. Further prospective studies are warranted to validate this relationship.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":"117 ","pages":"74-82"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interstitial pneumonitis due to everolimus in a liver transplant recipient. 肝移植受者依维莫司引起的间质性肺炎。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2024.10887/2024
Pere Vaquer-Grimalt, Natalia Chausse, Maria Dolors Ramis Estelrich, María Belén Núñez, Aina Escarda, Llucia Bonet, Lydia Sastre Oliver, Margalida Vanrell

This is a case report of a patient with a history of liver transplant who developed interstitial pneumonitis due to immunosuppressive treatment. Everolimus-induced pneumonitis in liver transplant recipients is a rare condition. This observation aims to highlight the significance of being aware of this condition, being suspicious of it, and getting a proper diagnosis and treatment.

本文报告一例有肝移植史的患者因免疫抑制治疗而发生间质性肺炎。依维莫司引起的肝移植受者肺炎是一种罕见的疾病。这一观察旨在强调意识到这种情况,怀疑它,并得到适当的诊断和治疗的重要性。
{"title":"Interstitial pneumonitis due to everolimus in a liver transplant recipient.","authors":"Pere Vaquer-Grimalt, Natalia Chausse, Maria Dolors Ramis Estelrich, María Belén Núñez, Aina Escarda, Llucia Bonet, Lydia Sastre Oliver, Margalida Vanrell","doi":"10.17235/reed.2024.10887/2024","DOIUrl":"10.17235/reed.2024.10887/2024","url":null,"abstract":"<p><p>This is a case report of a patient with a history of liver transplant who developed interstitial pneumonitis due to immunosuppressive treatment. Everolimus-induced pneumonitis in liver transplant recipients is a rare condition. This observation aims to highlight the significance of being aware of this condition, being suspicious of it, and getting a proper diagnosis and treatment.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"123"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is fluoroscopy necessary for esophageal self-expanding metal stents placement? A retrospective cohort study. 食管SEMS放置需要透视吗?回顾性队列研究。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2025.11330/2025
Luís Miguel Relvas, Tânia Gago, Sónia Barros, Isabel Carvalho, Margarida Portugal, Francisco Velasco, Paulo Caldeira, Bruno Peixe

Introduction: self-expanding metal stents (SEMS) are widely used for the palliation of malignant esophageal conditions, including strictures, fistulas, and extrinsic compression. Placement may be guided by fluoroscopy, direct endoscopy, or both. However, few studies have directly compared the outcomes of these techniques.

Objective: to compare the safety and efficacy of SEMS placement under endoscopic versus fluoroscopic control in a real-world clinical setting.

Methods: we conducted a retrospective observational study of adult patients who underwent esophageal SEMS placement between January 2011 and December 2023. Patients were assigned to either the endoscopic control (EC) or fluoroscopic control (FC) group based on fluoroscopy availability. Outcomes included technical success, complication rates (early and late), and overall survival.

Results: a total of 103 patients were included (mean age 69.4 years; 79 % male), with 43 receiving SEMS under EC and 60 under FC. The primary indication was malignant esophageal stricture (91.3 %). Technical success was achieved in 97 % of EC cases and 100 % of FC cases. Early complications occurred in 53 % of EC and 49 % of FC patients (p = 0.70), including chest pain (40.7 %), vomiting (22.3 %), and stent migration (5.8 %). Late complications occurred in 28 % of EC and 31 % of FC cases (p = 0.74), most commonly tumor overgrowth (14.6 %) and stent migration (10.7 %). Thirty-day mortality was 2.3 % in the EC group and 0 % in the FC group (p = 0.31). Median survival was 102 days (EC) versus 113 days (FC) (p = 0.44).

Conclusions: SEMS placement under both endoscopic and fluoroscopic control is safe and effective, with no significant differences in complication rates, technical success, or survival. Endoscopic guidance may be a viable alternative to fluoroscopy in experienced hands, particularly in resource-limited settings.

自膨胀金属支架(SEMS)被广泛用于缓解恶性食管疾病,包括狭窄、瘘管和外在压迫。放置可以通过透视(FC),直接内窥镜(EC)或两者指导。然而,很少有研究直接比较这些技术的结果。目的:在现实世界的临床环境中,比较内镜下与透视下放置SEMS的安全性和有效性。方法:我们对2011年1月至2023年12月期间接受食管SEMS安置的成年患者进行了回顾性观察研究。根据透视检查的可用性,将患者分为EC组或FC组。结果包括技术成功、并发症发生率(早期和晚期)和总生存率。结果:共纳入103例患者(平均年龄69.4岁,男性79%),EC组43例接受SEMS, FC组60例。主要指征为恶性食管狭窄(91.3%)。97%的EC病例和100%的FC病例取得了技术上的成功。53%的EC和49%的FC患者出现早期并发症(p = 0.70),包括胸痛(40.7%)、呕吐(22.3%)和支架移位(5.8%)。晚期并发症发生在28%的EC和31%的FC (p = 0.74),最常见的是肿瘤过度生长(14.6%)和支架迁移(10.7%)。EC组30天死亡率为2.3%,FC组为0% (p = 0.31)。中位生存期为102天(EC) vs 113天(FC) (p = 0.44)。结论:在内镜和透视控制下放置SEMS是安全有效的,在并发症发生率、技术成功率或生存率方面没有显著差异。在经验丰富的人员中,内镜指导可能是透视检查的可行替代方法,特别是在资源有限的情况下。
{"title":"Is fluoroscopy necessary for esophageal self-expanding metal stents placement? A retrospective cohort study.","authors":"Luís Miguel Relvas, Tânia Gago, Sónia Barros, Isabel Carvalho, Margarida Portugal, Francisco Velasco, Paulo Caldeira, Bruno Peixe","doi":"10.17235/reed.2025.11330/2025","DOIUrl":"10.17235/reed.2025.11330/2025","url":null,"abstract":"<p><strong>Introduction: </strong>self-expanding metal stents (SEMS) are widely used for the palliation of malignant esophageal conditions, including strictures, fistulas, and extrinsic compression. Placement may be guided by fluoroscopy, direct endoscopy, or both. However, few studies have directly compared the outcomes of these techniques.</p><p><strong>Objective: </strong>to compare the safety and efficacy of SEMS placement under endoscopic versus fluoroscopic control in a real-world clinical setting.</p><p><strong>Methods: </strong>we conducted a retrospective observational study of adult patients who underwent esophageal SEMS placement between January 2011 and December 2023. Patients were assigned to either the endoscopic control (EC) or fluoroscopic control (FC) group based on fluoroscopy availability. Outcomes included technical success, complication rates (early and late), and overall survival.</p><p><strong>Results: </strong>a total of 103 patients were included (mean age 69.4 years; 79 % male), with 43 receiving SEMS under EC and 60 under FC. The primary indication was malignant esophageal stricture (91.3 %). Technical success was achieved in 97 % of EC cases and 100 % of FC cases. Early complications occurred in 53 % of EC and 49 % of FC patients (p = 0.70), including chest pain (40.7 %), vomiting (22.3 %), and stent migration (5.8 %). Late complications occurred in 28 % of EC and 31 % of FC cases (p = 0.74), most commonly tumor overgrowth (14.6 %) and stent migration (10.7 %). Thirty-day mortality was 2.3 % in the EC group and 0 % in the FC group (p = 0.31). Median survival was 102 days (EC) versus 113 days (FC) (p = 0.44).</p><p><strong>Conclusions: </strong>SEMS placement under both endoscopic and fluoroscopic control is safe and effective, with no significant differences in complication rates, technical success, or survival. Endoscopic guidance may be a viable alternative to fluoroscopy in experienced hands, particularly in resource-limited settings.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"88-94"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulty in cannulation and risk of complications after endoscopic retrograde cholangiopancreatography according to the type of papilla of Vater in a tertiary center. 三级中心水乳头类型对ERCP插管困难及并发症风险的影响。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2025.11475/2025
Renzo Pinto-Carta, Gustavo Adolfo Reyes Medina, Mariana Vásquez, Andrés Felipe Bejarano-Ramírez, María Alejandra Gómez-Gutiérrez, Fernando Sierra-Arango

Introduction: cannulation of the papilla of Vater is a critical step in endoscopic retrograde cholangiopancreatography (ERCP), with direct implications for procedural success and the risk of adverse events. Although endoscopist experience and anatomical variations are known contributors, the role of papillary morphology remains insufficiently explored in Latin America. This study aimed to assess the association between papilla type and cannulation difficulty or complications.

Materials and methods: adults with a native major papilla undergoing ERCP at a tertiary center in Bogotá were prospectively enrolled. Papillary morphology was classified macroscopically, and difficult cannulation was defined according to the European Society of Gastrointestinal Endoscopy (ESGE) criteria. Associations were analyzed using Fisher's exact test and odds ratios with 95 % confidence intervals. Fifty-eight patients (mean age 59.9 years, 63.8 % female) were included.

Results: the most common papilla was type 1 (63.8 %), followed by type 3 (27.6 %). Difficult cannulation occurred in 13.8 % of procedures, mostly involving type 1, type 3, and the single type 4 case. Advanced cannulation techniques were required in 34.5 % of cases and were associated with longer procedural times. Prophylactic measures were used in 60.3 % of patients. Overall, 6.9 % developed post-ERCP pancreatitis and 3.4 % cholangitis. No significant association was found between papilla type and complication rate.

Conclusion: our findings suggest that type 1 and type 3 papillae are more frequently associated with cannulation difficulty, although complication rates did not differ significantly by morphology. Recognizing papilla morphology may enhance preprocedural planning and training strategies in advanced endoscopy units.

水乳头插管是内镜逆行胆管造影(ERCP)的关键步骤,对手术成功和不良事件的风险有直接影响。虽然内窥镜医生的经验和解剖变异是已知的贡献者,但在拉丁美洲,乳头状形态的作用仍然没有得到充分的探讨。本研究旨在评估乳头类型与插管困难或并发症之间的关系。前瞻性纳入在波哥大三级中心接受ERCP的本地大乳头成人。从宏观上对乳头形态进行分类,根据ESGE标准定义插管困难。使用Fisher精确检验和95%置信区间的比值比分析相关性。共纳入58例患者,平均年龄59.9岁,女性占63.8%。最常见的乳头是1型(63.8%),其次是3型(27.6%)。13.8%的手术出现插管困难,主要涉及1型、3型和单一的4型病例。34.5%的病例需要先进的插管技术,且手术时间较长。60.3%的患者采取了预防措施。总体而言,6.9%发生ercp后胰腺炎,3.4%发生胆管炎。乳头类型与并发症发生率无显著相关性。我们的研究结果表明,1型和3型乳头更常与插管困难相关,尽管并发症的发生率在形态上没有显着差异。认识乳头形态可以提高术前计划和训练策略在先进的内窥镜单位。
{"title":"Difficulty in cannulation and risk of complications after endoscopic retrograde cholangiopancreatography according to the type of papilla of Vater in a tertiary center.","authors":"Renzo Pinto-Carta, Gustavo Adolfo Reyes Medina, Mariana Vásquez, Andrés Felipe Bejarano-Ramírez, María Alejandra Gómez-Gutiérrez, Fernando Sierra-Arango","doi":"10.17235/reed.2025.11475/2025","DOIUrl":"10.17235/reed.2025.11475/2025","url":null,"abstract":"<p><strong>Introduction: </strong>cannulation of the papilla of Vater is a critical step in endoscopic retrograde cholangiopancreatography (ERCP), with direct implications for procedural success and the risk of adverse events. Although endoscopist experience and anatomical variations are known contributors, the role of papillary morphology remains insufficiently explored in Latin America. This study aimed to assess the association between papilla type and cannulation difficulty or complications.</p><p><strong>Materials and methods: </strong>adults with a native major papilla undergoing ERCP at a tertiary center in Bogotá were prospectively enrolled. Papillary morphology was classified macroscopically, and difficult cannulation was defined according to the European Society of Gastrointestinal Endoscopy (ESGE) criteria. Associations were analyzed using Fisher's exact test and odds ratios with 95 % confidence intervals. Fifty-eight patients (mean age 59.9 years, 63.8 % female) were included.</p><p><strong>Results: </strong>the most common papilla was type 1 (63.8 %), followed by type 3 (27.6 %). Difficult cannulation occurred in 13.8 % of procedures, mostly involving type 1, type 3, and the single type 4 case. Advanced cannulation techniques were required in 34.5 % of cases and were associated with longer procedural times. Prophylactic measures were used in 60.3 % of patients. Overall, 6.9 % developed post-ERCP pancreatitis and 3.4 % cholangitis. No significant association was found between papilla type and complication rate.</p><p><strong>Conclusion: </strong>our findings suggest that type 1 and type 3 papillae are more frequently associated with cannulation difficulty, although complication rates did not differ significantly by morphology. Recognizing papilla morphology may enhance preprocedural planning and training strategies in advanced endoscopy units.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":"117 ","pages":"83-87"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute acalculous cholecystitis secondary to hepatitis A infection. 继发于甲型肝炎感染的急性结石性胆囊炎。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2024.10941/2024
Irene González Díaz, Marta Abadía Barnó, Carmen Amor Costa, Clara Amiama Roig

Acute acalculous cholecystitis (AAC) of infectious origin represents a small percentage of all cases of cholecystitis. According to the literature, the most common pathogens include Salmonella typhii and Epstein-Barr virus (EBV). However, AAC has also been described as a rare complication in the context of other viral hepatitis infections, with only a few reported cases attributed to hepatitis A virus (HAV) infection. We present the case of a patient with AAC secondary to HAV infection, which resolved favorably with conservative management. We report the case of a 29-year-old male presenting with jaundice, abdominal pain, and fever lasting three days. Laboratory results revealed elevated transaminase levels with a cholestatic pattern and hyperbilirubinemia, predominantly direct bilirubin. Abdominal ultrasound showed a gallbladder with a thickened, heterogeneous, poorly defined, and disorganized wall, along with multiple enlarged perihilar lymph nodes and a positive Murphy's sign. Serological testing for hepatopathy revealed positive IgM antibodies for HAV, confirming the diagnosis of hepatitis A. Seven days later, follow-up testing demonstrated normalization of both laboratory parameters and ultrasound findings following resolution of the viral illness.

感染性急性无结节性胆囊炎(AAC)在所有胆囊炎病例中只占一小部分。根据文献记载,最常见的病原体包括伤寒沙门氏菌和爱泼斯坦-巴氏病毒(EBV)。 然而,AAC 也被描述为其他病毒性肝炎感染的罕见并发症,仅有少数报告病例归因于甲型肝炎病毒(HAV)感染。我们报告了一例继发于甲型肝炎病毒感染的 AAC 患者,该患者经保守治疗后病情好转。我们报告的病例是一名 29 岁的男性,出现黄疸、腹痛和持续三天的发热。实验室检查结果显示转氨酶水平升高,伴有胆汁淤积型和高胆红素血症,主要是直接胆红素。腹部超声波检查显示胆囊壁增厚、异质、轮廓不清且杂乱无章,胆囊周围淋巴结肿大,墨菲氏征阳性。肝病血清学检测显示 HAV IgM 抗体阳性,确诊为甲型肝炎。七天后,随访检测显示,病毒性疾病缓解后,实验室指标和超声检查结果均恢复正常。
{"title":"Acute acalculous cholecystitis secondary to hepatitis A infection.","authors":"Irene González Díaz, Marta Abadía Barnó, Carmen Amor Costa, Clara Amiama Roig","doi":"10.17235/reed.2024.10941/2024","DOIUrl":"10.17235/reed.2024.10941/2024","url":null,"abstract":"<p><p>Acute acalculous cholecystitis (AAC) of infectious origin represents a small percentage of all cases of cholecystitis. According to the literature, the most common pathogens include Salmonella typhii and Epstein-Barr virus (EBV). However, AAC has also been described as a rare complication in the context of other viral hepatitis infections, with only a few reported cases attributed to hepatitis A virus (HAV) infection. We present the case of a patient with AAC secondary to HAV infection, which resolved favorably with conservative management. We report the case of a 29-year-old male presenting with jaundice, abdominal pain, and fever lasting three days. Laboratory results revealed elevated transaminase levels with a cholestatic pattern and hyperbilirubinemia, predominantly direct bilirubin. Abdominal ultrasound showed a gallbladder with a thickened, heterogeneous, poorly defined, and disorganized wall, along with multiple enlarged perihilar lymph nodes and a positive Murphy's sign. Serological testing for hepatopathy revealed positive IgM antibodies for HAV, confirming the diagnosis of hepatitis A. Seven days later, follow-up testing demonstrated normalization of both laboratory parameters and ultrasound findings following resolution of the viral illness.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"115-116"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intestinal graft-versus-host disease. 肠道移植物抗宿主疾病。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2024.10831/2024
Luis Carlos Anflor, Luana Posser, Julia Sarkis, Luiz Felipe Peres Giesta, Daniara Viegas Rebelo Assis, Emanuella Lara Tarzo de Medina Coeli, Meligreize Zan, Pedro Vieceli Jardim

Graft-versus-host disease (GVHD) is a significant complication of allogeneic hematopoietic cell transplantation, an immune response against the host's tissues, resulting in inflammation and intestinal damage. GVHD is one of the leading causes of morbidity and mortality in this group of people, with an incidence of approximately 29.9% to 36% in acute grade II-IV gastrointestinal cases. Thus, the following is a report of a GVHD case where radiological findings were essential for diagnosis and treatment.

移植物抗宿主病(GVHD)是异基因造血细胞移植的一种重要并发症,是一种针对宿主组织的免疫反应,会导致炎症和肠道损伤。GVHD 是导致这类人群发病和死亡的主要原因之一,在急性 II-IV 级胃肠道病例中的发病率约为 29.9% 至 36%。因此,以下是一例 GVHD 病例的报告,其中放射学检查结果对诊断和治疗至关重要。
{"title":"Intestinal graft-versus-host disease.","authors":"Luis Carlos Anflor, Luana Posser, Julia Sarkis, Luiz Felipe Peres Giesta, Daniara Viegas Rebelo Assis, Emanuella Lara Tarzo de Medina Coeli, Meligreize Zan, Pedro Vieceli Jardim","doi":"10.17235/reed.2024.10831/2024","DOIUrl":"10.17235/reed.2024.10831/2024","url":null,"abstract":"<p><p>Graft-versus-host disease (GVHD) is a significant complication of allogeneic hematopoietic cell transplantation, an immune response against the host's tissues, resulting in inflammation and intestinal damage. GVHD is one of the leading causes of morbidity and mortality in this group of people, with an incidence of approximately 29.9% to 36% in acute grade II-IV gastrointestinal cases. Thus, the following is a report of a GVHD case where radiological findings were essential for diagnosis and treatment.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"114-115"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystic pancreatic lesions: when to watch and when to act? 囊性胰腺病变:何时观察,何时采取行动?
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2025.11428/2025
Yessica Domínguez Novoa, J Enrique Domínguez-Muñoz, José Lariño Noia, Julio Iglesias-García

Cystic pancreatic lesions (CPL) represent a growing challenge in gastroenterology, as their detection becomes more prevalent, and their management is increasingly complex. While many CPLs are benign and require only observation, others carry a significant risk of malignant transformation. The key to effective management relies in an accurate risk stratification, which can guide decisions regarding surveillance and treatment. As we move towards more personalized, patient-centered approaches, it is crucial to balance the benefits of early detection and intervention with the risks of overtreatment and the psychological burden on patients. Advances in molecular diagnostics and imaging, combined with improved patient education and shared decision-making, will be essential in shaping the future of CPLs management. The goal is not only to improve patient outcomes but also to ensure that care is compassionate, cost-effective, and aligned with individual patient needs.

囊性胰腺病变(CPL)在胃肠病学中是一个越来越大的挑战,因为它们的检测变得越来越普遍,而且它们的治疗也越来越复杂。虽然许多cpl是良性的,只需要观察,但其他cpl有明显的恶性转化风险。有效管理的关键在于准确的风险分层,这可以指导有关监测和治疗的决策。随着我们转向更加个性化、以患者为中心的方法,在早期发现和干预的好处与过度治疗的风险以及患者的心理负担之间取得平衡至关重要。分子诊断和成像技术的进步,加上患者教育的改善和共同决策的制定,对于塑造cpl管理的未来至关重要。目标不仅是改善患者的治疗效果,而且要确保护理是富有同情心的、具有成本效益的,并与患者的个人需求保持一致。
{"title":"Cystic pancreatic lesions: when to watch and when to act?","authors":"Yessica Domínguez Novoa, J Enrique Domínguez-Muñoz, José Lariño Noia, Julio Iglesias-García","doi":"10.17235/reed.2025.11428/2025","DOIUrl":"10.17235/reed.2025.11428/2025","url":null,"abstract":"<p><p>Cystic pancreatic lesions (CPL) represent a growing challenge in gastroenterology, as their detection becomes more prevalent, and their management is increasingly complex. While many CPLs are benign and require only observation, others carry a significant risk of malignant transformation. The key to effective management relies in an accurate risk stratification, which can guide decisions regarding surveillance and treatment. As we move towards more personalized, patient-centered approaches, it is crucial to balance the benefits of early detection and intervention with the risks of overtreatment and the psychological burden on patients. Advances in molecular diagnostics and imaging, combined with improved patient education and shared decision-making, will be essential in shaping the future of CPLs management. The goal is not only to improve patient outcomes but also to ensure that care is compassionate, cost-effective, and aligned with individual patient needs.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"71-73"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144754144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-endoscopic retrograde cholangiopancreatography bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report. 先前接受阿特唑单抗-贝伐单抗治疗的肝移植受体ercp后肠内脏切除:第一份报告。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2025.11518/2025
Elena Santos-Pérez, Cecile Gomercic, Maxime Thobois, Anne-Claire Frin, Dann Ouizeman, Geoffroy Vanbiervliet, Michel Rayar, Rodolphe Anty

Hepatocellular carcinoma (HCC) treatment increasingly involves liver transplantation (LT), often after downstaging therapies. Atezolizumab, a PD-L1 inhibitor, combined with bevacizumab, an anti-VEGF agent, is widely used, showing high response rates pre-transplant. However, bevacizumab impairs angiogenesis and can significantly increase the risk of wound dehiscence, infection, and delayed healing after major surgery, including LT.

肝细胞癌(HCC)的治疗越来越多地涉及肝移植(LT),通常在降低分期治疗后。Atezolizumab是一种PD-L1抑制剂,与抗vegf药物贝伐单抗联合使用,在移植前显示出很高的应答率。然而,贝伐单抗会损害血管生成,并可显著增加包括肝移植在内的大手术后伤口裂开、感染和延迟愈合的风险。
{"title":"Post-endoscopic retrograde cholangiopancreatography bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report.","authors":"Elena Santos-Pérez, Cecile Gomercic, Maxime Thobois, Anne-Claire Frin, Dann Ouizeman, Geoffroy Vanbiervliet, Michel Rayar, Rodolphe Anty","doi":"10.17235/reed.2025.11518/2025","DOIUrl":"10.17235/reed.2025.11518/2025","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) treatment increasingly involves liver transplantation (LT), often after downstaging therapies. Atezolizumab, a PD-L1 inhibitor, combined with bevacizumab, an anti-VEGF agent, is widely used, showing high response rates pre-transplant. However, bevacizumab impairs angiogenesis and can significantly increase the risk of wound dehiscence, infection, and delayed healing after major surgery, including LT.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"109-110"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145346863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperplasia of Brunner's glands as a cause of gastrointestinal bleeding in a young patient: an endoscopic approach. 布鲁纳氏腺体增生是一名年轻患者消化道出血的原因:内窥镜方法。
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2024.10347/2024
Celina González Peña, Samuel Ayón Ahumada

Brunner's gland hyperplasia or Brunneroma is a rare benign proliferative lesion of the small intestine. It is often incidentally discovered during endoscopy or imaging studies. The endoscopic presentation can be nodular, polypoid, or a diffuse glandular proliferation with thickening of the duodenal wall, which can be mistaken for malignant neoplasia. It rarely causes gastrointestinal bleeding. Is presented a case of a 25-year-old man who presented with melena and anemia secondary to Brunner's gland hyperplasia.

布鲁纳腺增生症或布鲁纳瘤是一种罕见的小肠良性增生性病变。它通常是在内镜或造影检查中偶然发现的。内镜下表现为结节状、息肉状或弥漫性腺体增生,十二指肠壁增厚,可误诊为恶性肿瘤。它很少引起消化道出血。本文介绍了一例 25 岁男子因布鲁纳氏腺体增生继发血便和贫血的病例。
{"title":"Hyperplasia of Brunner's glands as a cause of gastrointestinal bleeding in a young patient: an endoscopic approach.","authors":"Celina González Peña, Samuel Ayón Ahumada","doi":"10.17235/reed.2024.10347/2024","DOIUrl":"10.17235/reed.2024.10347/2024","url":null,"abstract":"<p><p>Brunner's gland hyperplasia or Brunneroma is a rare benign proliferative lesion of the small intestine. It is often incidentally discovered during endoscopy or imaging studies. The endoscopic presentation can be nodular, polypoid, or a diffuse glandular proliferation with thickening of the duodenal wall, which can be mistaken for malignant neoplasia. It rarely causes gastrointestinal bleeding. Is presented a case of a 25-year-old man who presented with melena and anemia secondary to Brunner's gland hyperplasia.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"101-102"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140102375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic vacuum therapy for leaky cavities: is it possible? 内窥镜真空疗法治疗漏孔:可行吗?
IF 4 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 DOI: 10.17235/reed.2024.10847/2024
Francesc Bas-Cutrina, Víctor Jair Morales-Alvarado, Marta Gomis-Martí, Erica Jiménez-Serrano, Elvira Rodríguez-Jiménez, Carme García-Abollo, Olga Silva, Sergio Bazaga

A 71-year-old male patient with a history of bladder neoplasia underwent Bricker-type surgery, during which an iatrogenic rectal injury occurred. During surgery, an unsuccessful suture attempt was made, leading to the appearance of fecaluria after 48 hours. A computed tomography scan revealed a small continuity defect in the rectal wall, accompanied by a 25-mm adjacent collection. Percutaneous drainage was placed in an attempt to achieve spontaneous closure, but this was unsuccessful. A rectoscopy was performed, identifying a wall defect in the mid-rectum. A review with a paediatric gastroscope confirmed communication to a cavity drained by urethra (recto-urethral fistula). Endoscopic vacuum therapy (EVT) (Endo-SPONGE®, B.Braun; Melsungen, Hesse, Germany) was initiated, achieving negative pressures (KCI Acelity V.A.C.® ATS® Negative Pressure Wound Therapy Unit; -100 mmHg). An endoscopic review after 72 hours confirmed the appearance of granulation tissue and the initiation of cavity closure. After three replacements (a total of four sponges), cavity collapse was achieved, but complete closure of the orifice was not attained. An over-the-scope clip (OTSC® 11.5-14 mm type-t, Ovesco; Tübingen, Baden-Wurttemberg, Germany) was placed, but fecaluria persisted, albeit with lesser intensity. Ultimately, successful closure was achieved by placing a second over-the-scope clip, two conventional hemoclips (Novaclip-R3 16 mm, Vytil; Hangzhou, Zhejiang, China), and instilling endoscopic biodegradable cyanoacrylate adhesive (Glubran® 2, GEM; Viareggio, Lucca, Italy).

一名有膀胱肿瘤病史的 71 岁男性患者接受了布里克式手术,手术过程中发生了直肠先天性损伤。手术期间,由于缝合失败,导致患者在 48 小时后出现大便失禁。计算机断层扫描显示,直肠壁有一个小的连续性缺损,并伴有一个 25 毫米的邻近积液。患者接受了经皮引流术,试图实现自发闭合,但未能成功。进行了直肠镜检查,发现直肠中段有一处肠壁缺损。使用小儿胃镜进行检查后,确认与尿道引流的空腔相通(直肠尿道瘘)。开始进行内窥镜真空疗法(EVT)(Endo-SPONGE®,B.Braun;德国黑森州梅尔松根),实现负压(KCI Acelity V.A.C.® ATS® 负压伤口治疗装置;-100 mmHg)。72 小时后的内窥镜检查证实肉芽组织出现并开始闭合创腔。在更换了三次海绵(共四块海绵)后,创腔塌陷得以实现,但创口尚未完全闭合。患者被放置了一个窥镜夹(OTSC® 11.5-14 mm type-t,Ovesco;Tübingen,Baden-Wurttemberg,Germany),但粪尿依然存在,只是强度有所降低。最终,通过放置第二个镜下血夹和两个传统血夹(Novaclip-R3 16 毫米,Vytil;中国浙江杭州),以及灌注内窥镜生物可降解氰基丙烯酸酯粘合剂(Glubran® 2,GEM;意大利卢卡 Viareggio),成功完成了闭合。
{"title":"Endoscopic vacuum therapy for leaky cavities: is it possible?","authors":"Francesc Bas-Cutrina, Víctor Jair Morales-Alvarado, Marta Gomis-Martí, Erica Jiménez-Serrano, Elvira Rodríguez-Jiménez, Carme García-Abollo, Olga Silva, Sergio Bazaga","doi":"10.17235/reed.2024.10847/2024","DOIUrl":"10.17235/reed.2024.10847/2024","url":null,"abstract":"<p><p>A 71-year-old male patient with a history of bladder neoplasia underwent Bricker-type surgery, during which an iatrogenic rectal injury occurred. During surgery, an unsuccessful suture attempt was made, leading to the appearance of fecaluria after 48 hours. A computed tomography scan revealed a small continuity defect in the rectal wall, accompanied by a 25-mm adjacent collection. Percutaneous drainage was placed in an attempt to achieve spontaneous closure, but this was unsuccessful. A rectoscopy was performed, identifying a wall defect in the mid-rectum. A review with a paediatric gastroscope confirmed communication to a cavity drained by urethra (recto-urethral fistula). Endoscopic vacuum therapy (EVT) (Endo-SPONGE®, B.Braun; Melsungen, Hesse, Germany) was initiated, achieving negative pressures (KCI Acelity V.A.C.® ATS® Negative Pressure Wound Therapy Unit; -100 mmHg). An endoscopic review after 72 hours confirmed the appearance of granulation tissue and the initiation of cavity closure. After three replacements (a total of four sponges), cavity collapse was achieved, but complete closure of the orifice was not attained. An over-the-scope clip (OTSC® 11.5-14 mm type-t, Ovesco; Tübingen, Baden-Wurttemberg, Germany) was placed, but fecaluria persisted, albeit with lesser intensity. Ultimately, successful closure was achieved by placing a second over-the-scope clip, two conventional hemoclips (Novaclip-R3 16 mm, Vytil; Hangzhou, Zhejiang, China), and instilling endoscopic biodegradable cyanoacrylate adhesive (Glubran® 2, GEM; Viareggio, Lucca, Italy).</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":"112-114"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Enfermedades Digestivas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1